Mutual of America Capital Management LLC Acquires 1,368 Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)

Mutual of America Capital Management LLC raised its holdings in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 7.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,069 shares of the software maker’s stock after purchasing an additional 1,368 shares during the period. Mutual of America Capital Management LLC’s holdings in Allscripts Healthcare Solutions were worth $371,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Eaton Vance Management bought a new position in Allscripts Healthcare Solutions during the 1st quarter valued at approximately $30,000. Point72 Hong Kong Ltd raised its position in Allscripts Healthcare Solutions by 152.9% during the 1st quarter. Point72 Hong Kong Ltd now owns 2,119 shares of the software maker’s stock valued at $32,000 after purchasing an additional 1,281 shares during the last quarter. Eqis Capital Management Inc. raised its position in Allscripts Healthcare Solutions by 16.1% during the 1st quarter. Eqis Capital Management Inc. now owns 12,718 shares of the software maker’s stock valued at $191,000 after purchasing an additional 1,761 shares during the last quarter. One Wealth Advisors LLC bought a new position in Allscripts Healthcare Solutions during the 1st quarter valued at approximately $210,000. Finally, Versor Investments LP bought a new position in Allscripts Healthcare Solutions during the 1st quarter valued at approximately $228,000.

Several research analysts have recently issued reports on the company. Royal Bank of Canada increased their target price on Allscripts Healthcare Solutions from $17.00 to $19.00 and gave the stock an “outperform” rating in a research report on Friday, August 6th. Piper Sandler reissued a “neutral” rating and issued a $17.00 target price (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Friday, August 6th. Deutsche Bank Aktiengesellschaft increased their target price on Allscripts Healthcare Solutions from $15.00 to $17.00 and gave the stock a “hold” rating in a research report on Thursday, May 20th. SVB Leerink increased their target price on Allscripts Healthcare Solutions from $17.00 to $19.00 and gave the stock a “market perform” rating in a research report on Friday, August 6th. Finally, Zacks Investment Research lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating and set a $19.00 target price for the company. in a research report on Friday, July 16th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Allscripts Healthcare Solutions presently has an average rating of “Hold” and a consensus target price of $16.05.

In other Allscripts Healthcare Solutions news, insider Lisa Khorey sold 50,000 shares of the stock in a transaction on Thursday, August 5th. The stock was sold at an average price of $17.14, for a total transaction of $857,000.00. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Greg Garrison sold 77,381 shares of the firm’s stock in a transaction on Tuesday, September 7th. The stock was sold at an average price of $15.02, for a total value of $1,162,262.62. Following the completion of the transaction, the director now owns 47,813 shares in the company, valued at $718,151.26. The disclosure for this sale can be found here. Company insiders own 1.91% of the company’s stock.

Allscripts Healthcare Solutions stock opened at $13.85 on Wednesday. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $1.73 billion, a P/E ratio of 2.75, a PEG ratio of 2.63 and a beta of 1.03. The stock’s 50 day moving average is $16.57 and its 200 day moving average is $16.53. Allscripts Healthcare Solutions, Inc. has a twelve month low of $7.55 and a twelve month high of $19.00.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Wednesday, August 4th. The software maker reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.06. Allscripts Healthcare Solutions had a return on equity of 7.06% and a net margin of 49.61%. The company had revenue of $373.70 million for the quarter, compared to the consensus estimate of $372.51 million. As a group, equities analysts expect that Allscripts Healthcare Solutions, Inc. will post 0.56 EPS for the current year.

Allscripts Healthcare Solutions declared that its board has initiated a share buyback program on Wednesday, May 26th that permits the company to repurchase $350.00 million in outstanding shares. This repurchase authorization permits the software maker to purchase up to 14% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.

Allscripts Healthcare Solutions Profile

Allscripts Healthcare Solutions, Inc engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segment. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units.

Further Reading: How to invest in blue-chip stocks

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.